Evidence map›Paper›PMID 42761029›Full record

ArticleFrontiers in microbiology2026

Epidemiological characteristics and genetic evolution of rhinovirus in Jining City, 2024-2025.

Mingsheng Zhao, Tongyun Song, Wen Li, Yajuan Jiang, Yongjian Jia, Huixin Dou, Ying Yue, Boyan Jiao, Xiaoyu Wang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mingsheng Zhao *Institute of Immunology and Molecular Medicine, Jining Medical University, Jining, China.
Tongyun Song *Department of Laboratory, Rencheng Maternal and Child Health Hospital, Jining, China.
Wen Li *College of Clinical and Basic Medicine, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Yajuan JiangDepartment of Microbiological Laboratory, Jining Center for Disease Control and Prevention, Jining, China.
Yongjian JiaDepartment of Microbiological Laboratory, Jining Center for Disease Control and Prevention, Jining, China.
Huixin DouDepartment of Microbiological Laboratory, Jining Center for Disease Control and Prevention, Jining, China.
Ying YueDepartment of Infectious Disease Control, Jining Center for Disease Control and Prevention, Jining, China.
Boyan JiaoDepartment of Microbiological Laboratory, Jining Center for Disease Control and Prevention, Jining, China.
Xiaoyu WangDepartment of Microbiological Laboratory, Jining Center for Disease Control and Prevention, Jining, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To investigate the epidemiological characteristics and genetic evolution of rhinovirus (RV) among patients with influenza-like illness (ILI) in Jining City, Shandong Province, from 2024 to 2025, and to provide scientific evidence for the formulation of regional respiratory virus prevention and control strategies. Methods: A total of 2,724 throat swab specimens were collected from ILI cases at Jining First People's Hospital between 2024 and 2025. Ten respiratory viruses were screened using real-time reverse transcription-quantitative PCR. Of 101 RV-positive specimens, 30 with lower cycle threshold ( Results: Among the 2,724 specimens, influenza virus had the highest detection rate (14.98%), followed by SARS-CoV-2 (7.05%), with rhinovirus ranking third (3.71%, 101/2,724). The RV-positive rate in 2025 (5.53%) was significantly higher than in 2024 (1.95%; χ Conclusion: RV-A was the predominant rhinovirus species circulating in Jining City during 2024-2025, with high genotypic diversity. The detection rate in 2025 increased significantly compared with 2024, accompanied by an autumn epidemic peak. Rhinoviruses in this region exhibit ongoing evolution in the VP1 region. Enhanced molecular surveillance is warranted to dynamically monitor epidemiological and evolutionary trends.

Indexed as

genetic evolutionmolecular characterizationmolecular epidemiologyrespiratory virusrhinovirus

Identifiers

PMID42761029
PMCPMC13585650

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.